The NAFTA Pharmaceuticals industry profile provides top-line qualitative and quantitative Summary information including: market share, market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Essential resource for top-line data and analysis covering the NAFTA pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.
Browse Full Research Report With TOC on: http://www.radiantinsights.com/research/pharmaceuticals-north-america-nafta-industry-guide-2017
- The North American Free Trade Agreement (NAFTA) is a trade agreement between the countries in North America: the US, Canada and Mexico. The pharmaceuticals industry within the NAFTA countries had a total market value of $416.8 billion in 2016.The Mexico was the fastest growing country, with a CAGR of 10.2% over the 2012-16 period.
- Within the pharmaceuticals industry, the US is the leading country among the NAFTA bloc, with market revenues of $377.0 billion in 2016. This was followed by Mexico and Canada, with a value of $19.9 and $19.9 billion, respectively.
- The US is expected to lead the pharmaceuticals industry in the NAFTA bloc, with a value of $530.8 billion in 2021, followed by Canada and Mexico with expected values of $27.7 and $25.6 billion, respectively.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the NAFTA pharmaceuticals market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the NAFTA pharmaceuticals market
- Leading company profiles reveal details of key pharmaceuticals market players’ NAFTA operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the NAFTA pharmaceuticals market with five year forecasts
- Compares data from the US, Canada and Mexico, alongside individual chapters on each country
Request A Sample Copy Of This Report at: http://www.radiantinsights.com/research/pharmaceuticals-north-america-nafta-industry-guide-2017/request-sample
Reasons To Buy:
- What was the size of the NAFTA pharmaceuticals market by value in 2016?
- What will be the size of the NAFTA pharmaceuticals market in 2021?
- What factors are affecting the strength of competition in the NAFTA pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in the NAFTA pharmaceuticals market?
Related Reports by Radiant Insights:
- Global Paclitaxel Injection Market-
- Global Asthma Treatment Drugs Market –
About Radiant Insights, Inc
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Corporate Sales Specialist, USA
Radiant Insights, Inc
Toll Free: 1-888-202-9519